sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
3-Aug-2015 06:41
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 976-1000 out of 1085.

<< < 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 > >>

Public Release: 31-Oct-2013
PLOS Neglected Tropical Diseases
Leading cause of heart disease ignored in North America's poorest communities
A leading cause of heart disease remains overlooked in North America's most impoverished communities, researchers said today in an editorial published in PLOS Neglected Tropical Diseases. Chagas disease has rendered a heavy health and economic toll, yet insufficient political and medical support for gathering specific data, providing diagnosis and treatment, and developing new tools has impeded much-needed breakthroughs.

Contact: Deborah Elson

Public Release: 31-Oct-2013
PLOS Neglected Tropical Diseases
Study tracks risk of VL exposure in Brazil's urban areas
The factors involved in VL transmission are poorly understood, especially in urban and densely populated counties. Dr. Mariangela Carneiro, Federal University of Minas Gerais, Brazil, and colleagues conducted studies on urbanization and expansion of VL in Belo Horizonte, capital of Minas Gerais State.

Contact: Mariangela Carneiro

Public Release: 31-Oct-2013
PLOS Neglected Tropical Diseases
Microsatellite DNA analysis reveals genetic change of P. vivax in Korea, 2002-2003
Malaria is one of the major infectious diseases transmitted by mosquitos, with enormous impact on quality of life. According to World Health Organization figures, as of 2010 there were over 219 million reported cases of malaria with an estimated 660,000 deaths. Plasmodium vivax, which is the second most prevalent species of the human malaria parasite, is widely distributed around the world especially in Asia, Melanesia, the Middle East, South and Central America. 2.85 billion people worldwide live at risk of the infection in 2009.

Contact: Ryouhei Nishigaya

Public Release: 30-Oct-2013
International Journal of Molecular Sciences
BUSM researchers study epigenetic mechanisms of tumor metastasis for improved cancer therapy
A review article by researchers at Boston University School of Medicine suggests that epigenetics may be a useful target to stop the growth, spread and relapse of cancer.

Contact: Gina Orlando
Boston University Medical Center

Public Release: 30-Oct-2013
New SARS-like coronavirus discovered in Chinese horseshoe bats
EcoHealth Alliance, a nonprofit organization that focuses on local conservation and global health issues, announced the discovery of a new SARS-like coronavirus (CoV) in Chinese horseshoe bats.
National Institutes of Health, National Science Foundation

Contact: Anthony M. Ramos
EcoHealth Alliance

Public Release: 30-Oct-2013
Pediatric Infectious Disease Journal
New look at old test may provide earlier detection of meningitis, MU researchers find
Researchers from the University of Missouri School of Medicine have found a more accurate method to screen for bacterial meningococcal infection in its early stages, when it's hardest to detect. According to the researchers, the method for diagnosis could save lives by getting patients treatment earlier, when the infection is most treatable.

Contact: Jeff Hoelscher
University of Missouri-Columbia

Public Release: 29-Oct-2013
PLOS Biology
New molecular target for malaria control identified
A new study led by Harvard School of Public Health and University of Perugia researchers has shown that egg development in the mosquito species primarily responsible for spreading malaria depends on a switch in the female that is turned on by a male hormone delivered during sex. Blocking the activation of this switch could impair the ability of the species, Anopheles gambiae, to reproduce, and may be a viable future strategy for mosquito and malaria control.
European Research Council, Wellcome Trust, Harvard School of Public Health

Contact: Marge Dwyer
Harvard School of Public Health

Public Release: 29-Oct-2013
PLOS Biology
New molecular target for malaria control identified
Malaria is a leading cause of death in tropical and subtropical regions and it is transmitted by a bite from infected female mosquitoes. According to the US Centers for Disease Control, malaria claims nearly 660,000 lives per year, 90 percent of them in Africa--and most of them children. There were an estimated 216 million malaria cases worldwide in 2010, mostly among pregnant women and children.

Contact: PLOS Biology

Public Release: 25-Oct-2013
Journal of General Internal Medicine
Social service barriers delay care among women with abnormal cancer screening
A recent study performed by researchers at Boston Medical Center, Boston University School of Medicine, Boston University School of Public Health, and Tufts Medical Center found that women with multiple barriers to healthcare, especially those with social barriers such as problems with housing and income, experienced delays in cancer screening follow up compared to those with fewer barriers or no social barriers.

Contact: Gina Orlando
Boston University Medical Center

Public Release: 25-Oct-2013
International Journal of Global Warming
Loss and damage from climate change
An open access special issue of the International Journal of Global Warming brings together, for the first time, empirical evidence of loss and damage from the perspective of affected people in nine vulnerable countries. The articles in this special issue show how climatic stressors affect communities, what measures households take to prevent loss and damage, and what the consequences are when they are unable to adjust sufficiently.

Contact: Albert Ang
Inderscience Publishers

Public Release: 24-Oct-2013
Journal of Nutrition
New testing strategy detects population-wide vitamin and mineral deficiencies
Levels of certain proteins in the bloodstream may be used to estimate levels of essential vitamins and minerals without directly testing for each nutritional factor. Researchers used a new strategy that allowed them to indirectly measure amounts of multiple nutrients in multiple people at the same time, an advance that should make it possible to rapidly detect nutritional deficiencies of an entire population, apply remediation efforts and test their worth within months instead of years.
Bill & Melinda Gates Foundation, Sight & Life Research Institute, US Agency for International Development

Contact: Catherine Kolf
Johns Hopkins Medicine

Public Release: 24-Oct-2013
Lancet Global Health
Deadly gaps persist in new drug development for neglected diseases
In a study published today in the open-access journal the Lancet Global Health, the Drugs for Neglected Diseases initiative and other researchers report a persistent deficiency in truly new therapeutics for neglected diseases, despite nominal progress and an acceleration in research and development (R&D) efforts. This continued "fatal imbalance" in medical R&D points to the urgent need to develop and deliver groundbreaking new treatments for the world's poorest and most neglected patients.

Contact: Oliver Yun
Drugs for Neglected Diseases Initiative

Public Release: 23-Oct-2013
'Saving Brains' of kids in developing countries: Grand Challenges Canada funds 14 bold new ideas
A new project in Ghana will demonstrate how medical staff and parents anywhere can use simple, affordable ways of soothing infants and reduce the damage to the brains of pre-term babies caused by the chronic pain of hospital needles and other daily procedures. It is one of 14 creative ideas for improving the early brain development of children in low-resource countries to be supported with CDN $10.1 million from Grand Challenges Canada, funded by the Government of Canada.

Contact: Terry Collins
Grand Challenges Canada

Public Release: 22-Oct-2013
McGill/MUHC research team wins global innovation award for HIVSmart self-screening strategy and app
The Research Institute of the McGill University Health Centre and McGill University congratulate the team led by Dr. Nitika Pant Pai for receiving the international 2013 Accelerating Science Award Program. The team won global recognition for developing an innovative self-test screening strategy for the HIV. The award, funded by Public Library of Science, Google and Wellcome Trust, recognizes scientific innovations borne out of Open Access research that address real world challenges.
Public Library of Science, Google, Wellcome Trust

Contact: Julie Robert
514-934-1934 x71381
McGill University Health Centre

Public Release: 22-Oct-2013
Proceedings of the National Academy of Sciences
New artificial protein mimics a part of the HIV outer coat
A team of scientists at Duke Medicine and Memorial Sloan-Kettering Cancer Center has created an artificial protein coupled with a sugar molecule that mimics a key site on the outer coat of HIV where antibodies can bind to neutralize a wide variety of HIV strains.
NIH/National Institute of Allergy and Infectious Diseases, Bill and Melinda Gates Foundation

Contact: Sarah Avery
Duke University Medical Center

Public Release: 22-Oct-2013
BUSM researchers make a case for free fatty acids
In a recent study in the journal Biochemistry, a research group led by James A. Hamilton, PhD, professor of physiology, biophysics and radiology at Boston University School of Medicine, applied novel fluorescent methods to measure the rate by which fatty acids bind to and move across the fatty acid membrane to become metabolized.

Contact: Gina Orlando
Boston University Medical Center

Public Release: 22-Oct-2013
Lauren Sciences LLC research team at Ben-Gurion University successfully completes Campbell Foundation 1-year grant to develop V-SmartTM therapeutic for neuro-HIV
Lauren Sciences, a privately-held biotechnology company furthering development of V-Smart™ therapeutics based upon its novel nanovesicle platform technology, announced today successful completion by its research team at Ben-Gurion University of the first stage of developing a V-Smart™ therapeutic for the treatment of neuro-HIV. The development of this V-Smart™ therapeutic, that systemically delivers tenofovir across the blood brain barrier into the brain for treatment of neuro-HIV, was supported by a grant from The Campbell Foundation.
Campbell Foundation

Contact: Susan Rosenbaum
Lauren Sciences LLC

Public Release: 21-Oct-2013
American Journal of Public Health
Study of decline of malaria in the US could affect approach to malaria epidemic abroad, UT Arlington researcher says
A study of the eradication of the mosquito-borne disease in the US has implications for the approach to malaria abroad, says Daniel Sledge, assistant professor of political science.

Contact: Bridget Lewis
University of Texas at Arlington

Public Release: 21-Oct-2013
IPM receives 2 awards from USAID through PEPFAR to advance HIV prevention technologies for women
The International Partnership for Microbicides announced today that it has received two competitive five-year awards with a combined US$40 million ceiling from the US Agency for International Development provided through the US President's Emergency Plan for AIDS Relief (PEPFAR). Both awards aim to advance new HIV prevention tools for women and to help ensure their availability in developing countries where the epidemic has hit hardest.

Contact: Holly Seltzer
International Partnership for Microbicides (IPM)

Public Release: 21-Oct-2013
URC leads new USAID project to improve Haiti's health care system
University Research Co., LLC is leading a new project in Haiti, a country with complex public health issues, to improve the population's health status. The project, called Quality Health Services for Haiti (Services de Santé de Qualité pour Haïti - SSQH) North, is funded by the US Agency for International Development. URC and its partners will support the Haitian Ministry of Public Health and Population to increase the use and quality of its primary care and community services.
US Agency for International Development

Contact: Elizabeth Ransom
University Research Co., LLC

Public Release: 21-Oct-2013
Proceedings of the National Academy of Sciences
Breast milk protein may be key to protecting babies from HIV infection
A substance in breast milk that neutralizes HIV and may protect babies from acquiring HIV from their infected mothers has been identified for the first time by researchers at Duke Medicine.
Doris Duke Charitable Foundation, Duke University School of Medicine, Center for HIV/AIDS Vaccine Immunology, NIH/National Institute of Allergy and Infectious Diseases

Contact: Sarah Avery
Duke University Medical Center

Public Release: 18-Oct-2013
Journal of Applied Physics
Salmonella sensing system
Foodborne illnesses spread easily and, as such, are a difficult-to-control problem -- even more so in developing nations. Quick detection can play a critical role in halting the spread of contamination. Traditional detection methods, however, tend to be haltingly slow. Recognizing the need for a real-time biosensing system to detect pathogenic bacteria, a team at Auburn University came up with a novel design, which they describe in the AIP's Journal of Applied Physics.

Contact: Jason Socrates Bardi
American Institute of Physics

Public Release: 17-Oct-2013
PLOS Neglected Tropical Diseases
5-year-old children are as likely to suffer from bilharzia as their mothers
Children of women harboring the bilharzia (schistosomiasis) worm during pregnancy are more likely to suffer the infection by the age of five years, a new study publishing Oct. 17, 2013, in the journal PLOS Neglected Tropical Diseases has found.

Contact: Dr. Robert Tweyongyere

Public Release: 17-Oct-2013
PLOS Neglected Tropical Diseases
Pioneering use of oral cholera vaccine during outbreak
A Medecins Sans Frontieres vaccination campaign of more than 300,000 people in Guinea shows feasibility of oral cholera vaccine for control of future epidemics.
Médecins Sans Frontières

Contact: Sandra Murillo

Public Release: 17-Oct-2013
PLOS Neglected Tropical Diseases
Human neutrophil peptide-1: A new anti-leishmanial drug candidate
As drug-resistant strains of Leishmaniasis spread, new non-toxic therapy could open a new front in the battle against this deadly parasite.
Pasteur Institute of Iran

Contact: Sima Rafati
98-216-695-3311 x21

Showing releases 976-1000 out of 1085.

<< < 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 > >>